SPEEDEL Pharma
Reports describe the most recent news from SPEEDEL Pharma
Published in Fitness and Wellness Business Week, August 22nd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at SPEEDEL Pharma.
Report 1: Speedel (SWX: SPPN) today announced that it has reached another significant milestone in the development of its family of renin inhibitors with the successful completion of a Phase IIa proof-of-concept clinical trial with SPP635 for the treatment of hypertension. Based on these positive results, the company is to continue developing SPP635 in Phase II in a special population of diabetic patients with mild-to-moderate hypertension. This compound is the first of a next...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Fitness and Wellness Business Week
More Articles from Fitness and Wellness Business Week
- Acne Vulgaris Prevention
Reports from Royal Melbourne Institute of Technology advance knowledge in acne vulgaris prevention - Algorithms
New algorithms research from J. Lim and colleagues discussed - Analytical Chemistry
New analytical chemistry study findings recently were reported by researchers at University of Missouri - Angiotensins
Research from H.L. Li and co-authors provides new data about angiotensins - Apoptosis Cell Biology
Researchers at Pusan National University, Department of Physiology publish new data on apoptosis cell biology - Applied Genetics
Research reports on applied genetics from National Chemical Laboratory provide new insights - More from this issue of Fitness and Wellness Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
